Page last updated: 2024-10-28

glipizide and Porphyrias

glipizide has been researched along with Porphyrias in 1 studies

Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research Excerpts

ExcerptRelevanceReference
"The glipizide regimen was discontinued; 2 months later, the stool coproporphyrins had decreased to normal levels."5.28A coproporphyria-like syndrome induced by glipizide. ( Moder, KG; Schwenk, NM, 1991)
"The glipizide regimen was discontinued; 2 months later, the stool coproporphyrins had decreased to normal levels."1.28A coproporphyria-like syndrome induced by glipizide. ( Moder, KG; Schwenk, NM, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moder, KG1
Schwenk, NM1

Other Studies

1 other study available for glipizide and Porphyrias

ArticleYear
A coproporphyria-like syndrome induced by glipizide.
    Mayo Clinic proceedings, 1991, Volume: 66, Issue:3

    Topics: Abdominal Pain; Contraindications; Coproporphyrins; Diabetes Mellitus, Type 2; Diagnosis, Differenti

1991